Position in VRDN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,862,327
+$2,229,028 QoQ
Shares Held
863,491
+23.9% QoQ
Ownership
0.762%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 215 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. VRDN ranks #91 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,862,327 | 863,491 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $13,633,299 | 696,999 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,801,134 | 668,417 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,398,199 | 620,862 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,344,422 | 596,883 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $9,469,926 | 702,517 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,306,700 | 694,142 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $13,231,580 | 581,608 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $6,243,250 | 479,881 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,101,525 | 462,680 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,009,099 | 413,641 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,161,554 | 401,666 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,655,526 | 405,865 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,436,356 | 370,926 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,564,933 | 361,689 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,595,352 | 272,811 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,822,570 | 243,956 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,044,443 | 56,487 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,172,913 | 59,328 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $570,008 | 34,651 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $575,531 | 31,467 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||